KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Sales (2018 - 2025)

Historic Return on Sales for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to 0.02%.

  • Amneal Pharmaceuticals' Return on Sales rose 100.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.03% for FY2024, which is 100.0% down from last year.
  • Amneal Pharmaceuticals' Return on Sales amounted to 0.02% in Q3 2025, which was up 100.0% from 0.05% recorded in Q2 2025.
  • Amneal Pharmaceuticals' Return on Sales' 5-year high stood at 0.06% during Q2 2021, with a 5-year trough of 0.43% in Q2 2022.
  • Moreover, its 5-year median value for Return on Sales was 0.0% (2022), whereas its average is 0.03%.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -4900bps in 2022, then skyrocketed by 4800bps in 2023.
  • Amneal Pharmaceuticals' Return on Sales (Quarter) stood at 0.04% in 2021, then skyrocketed by 75bps to 0.01% in 2022, then plummeted by -1476bps to 0.15% in 2023, then soared by 81bps to 0.03% in 2024, then skyrocketed by 181bps to 0.02% in 2025.
  • Its last three reported values are 0.02% in Q3 2025, 0.05% for Q2 2025, and 0.04% during Q1 2025.